Article
08 May 2026
Principals Noel Courage And Ainslie Parsons Explore Strategies For Protecting New Plant Varieties Across Key Markets
AUTHORS CONTENT
Article
23 Sep 2024
Building IP – Copyright Issues In The Construction Industry
Article
01 Nov 2023
Unveiling The Gaps: Year One Of CIHR's Clinical Trial Registration Rules
Article
31 Oct 2023
PMPRB Adopts Amended Interim Guidelines To Expedite New Patented Medicine Price Reviews
Article
23 Aug 2023
Challenging A Canadian Patent By Re-examination
Article
18 Jul 2023
Elevate IP - New Canadian Funding Program To Elevate Your IP Game
Article
19 May 2023
Intellectual Property Strategy For Protecting Software: Supplementing Utility Patent Protection With Industrial Designs
Article
23 Feb 2023
2022 Year In Review: Life Sciences
Article
12 Jan 2023
Canadian Grant Agency Raises Clinical Trial Reporting Requirements
Article
15 Dec 2022
Getting Transparent About Transparency: Canadian Registration And Reporting Of Clinical Trials
Article
02 Dec 2022
The Role Of IP Management In Product Development
Article
13 Nov 2022
PMPRB Regulations Saga Coming To An End? New Draft Guidelines Issued
Article
02 Nov 2022
Patent Applicants Dash To Avoid Costly New Canadian Rules
Article
29 Aug 2022
Is This Drug Safe And Effective Enough? Canadian Regulators Wade Into Alzheimer's Drug Controversy
Article
28 Jun 2022
One Person's Trash Is Another Person's Treasure – Where France Goes, Will Others Follow?
Article
06 May 2022
What's It Worth? Valuation Of IP
Article
25 Apr 2022
Canada Drops Its Most Controversial Patented Drug Pricing Amendments
Article
05 Apr 2022
Supreme Court Of Canada Takes A Pass On Patented Drug Price Dispute
Article
23 Mar 2022
Ontario Government Launches IP Agency To Support Innovators And Increase IP Value
Article
10 Mar 2022
2021 Year In Review: COVID-19